University Health System
 
Request an appointment online!
Careers at UHS About UHS Locations Patient Information Our Services Shop Online
 
Texas Diabetes Institute - Diabetes Research
About the Texas Diabetes Institute
Diabetes Education
Diabetes Care
Diabetes Research
Ongoing Studies
TDI home page
Go back a page
At-Risk for Diabetes
At-risk for Diabetes - Ongoing studies

Gestational diabetes

  • No studies at this time, please check back later.

Family members

  1. Effect of Pioglitazone versus Placebo Treatment on the Delay and/or Prevention of Type 2 Diabetes Mellitus in Subjects at High Risk for the Development of the Disease. IRB# 023-5014-209. Principal Investigator: Ralph A DeFronzo, MD-(210) 358-7200.

  2. Molecular Epidemiology of Type 2 Diabetes Mellitus in Mexican Americans. IRB# 923-5014-439. Principal Investigator: Ralph A DeFronzo, MD-(210) 358-7200.

Overweight

  1. The Role of Inflammatory, Adipocytokines, and Insulin Signaling and Sensitivity in the Prevention of Type 2 Diabetes Mellitus in Hypertensive Subjects Treated with Valsartan. IRB# HSC20070065H. Principal Investigator: Ralph DeFronzo, MD

  2. Effect of Pioglitazone versus Placebo Treatment on the Delay and/or Prevention of Type 2 Diabetes Mellitus in Subjects at High Risk for the Development of the Disease. IRB# 023-5014-209. Principal Investigator: Ralph A DeFronzo, MD-(210) 358-7200.
Return to top